Somatostatin Receptor Agonists [MoA] - N0000000194

Name: Table of NDC products with somatostatin receptor agonists
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000000194
Pharmacologic Name	Somatostatin Receptor Agonists
Pharmacologic Uses	somatostatin analog
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Somatostatin Receptor Agonists

The table contains 44 products whose active ingredient are classified under the same pharmacologic class Somatostatin Receptor Agonists [MoA].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0078-0180	Sandostatin	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Novartis Pharmaceuticals Corporation	ACTIVE
0078-0181	Sandostatin	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Novartis Pharmaceuticals Corporation	ACTIVE
0078-0182	Sandostatin	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Novartis Pharmaceuticals Corporation	ACTIVE
0641-6174	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Hikma Pharmaceuticals Usa Inc.	ACTIVE
0641-6175	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Hikma Pharmaceuticals Usa Inc.	ACTIVE
0641-6176	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Hikma Pharmaceuticals Usa Inc.	ACTIVE
0641-6177	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Hikma Pharmaceuticals Usa Inc.	ACTIVE
0641-6178	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Hikma Pharmaceuticals Usa Inc.	ACTIVE
10122-550	Mycapssa	Non-Proprietary Name: Octreotide	Capsule, Delayed Release	Oral	Chiesi Usa, Inc.	ACTIVE
15054-1060	Somatuline Depot	Non-Proprietary Name: Lanreotide Acetate	Injection	Subcutaneous	Ipsen Biopharmaceuticals, Inc.	ACTIVE
15054-1090	Somatuline Depot	Non-Proprietary Name: Lanreotide Acetate	Injection	Subcutaneous	Ipsen Biopharmaceuticals, Inc.	ACTIVE
15054-1120	Somatuline Depot	Non-Proprietary Name: Lanreotide Acetate	Injection	Subcutaneous	Ipsen Biopharmaceuticals, Inc.	ACTIVE
23155-685	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Intravenous	Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.	ACTIVE
23155-686	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.	ACTIVE
23155-687	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.	ACTIVE
23155-688	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.	ACTIVE
23155-689	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.	ACTIVE
25021-463	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Sagent Pharmaceuticals	ACTIVE
25021-464	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Sagent Pharmaceuticals	ACTIVE
25021-465	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Sagent Pharmaceuticals	ACTIVE
25021-466	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Sagent Pharmaceuticals	ACTIVE
25021-467	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Sagent Pharmaceuticals	ACTIVE
55292-131	Signifor	Non-Proprietary Name: Pasireotide	Injection	Subcutaneous	Recordati Rare Diseases, Inc.	ACTIVE
55292-132	Signifor	Non-Proprietary Name: Pasireotide	Injection	Subcutaneous	Recordati Rare Diseases, Inc.	ACTIVE
55292-133	Signifor	Non-Proprietary Name: Pasireotide	Injection	Subcutaneous	Recordati Rare Diseases, Inc.	ACTIVE
63323-376	Octreotide	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
63323-377	Octreotide	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
63323-378	Octreotide	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
63323-379	Octreotide	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
67457-239	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Mylan Institutional Llc	ACTIVE
67457-245	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Mylan Institutional Llc	ACTIVE
67457-246	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Mylan Institutional Llc	ACTIVE
68083-515	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Gland Pharma Limited	ACTIVE
68083-516	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Gland Pharma Limited	ACTIVE
68083-517	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Gland Pharma Limited	ACTIVE
68083-560	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Gland Pharma Limited	ACTIVE
68462-896	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Glenmark Pharmaceuticals Inc., Usa	ACTIVE
68462-897	Octreotide Acetate	Non-Proprietary Name: Octreotide Acetate	Injection, Solution	Intravenous; Subcutaneous	Glenmark Pharmaceuticals Inc., Usa	ACTIVE
69097-870	Lanreotide Acetate	Non-Proprietary Name: Lanreotide Acetate	Injection	Subcutaneous	Cipla Usa Inc.	ACTIVE
69097-880	Lanreotide Acetate	Non-Proprietary Name: Lanreotide Acetate	Injection	Subcutaneous	Cipla Usa Inc.	ACTIVE
69097-890	Lanreotide Acetate	Non-Proprietary Name: Lanreotide Acetate	Injection	Subcutaneous	Cipla Usa Inc.	ACTIVE
69880-120	Mycapssa	Non-Proprietary Name: Octreotide	Capsule, Delayed Release	Oral	Amryt Pharmaceuticals Designated Activity Company	ACTIVE